[1]霍春霞,谢 玲,张爱萍.早期干预治疗对早期筛查阳性子痫前期孕妇妊娠结局的影响[J].医学信息,2023,36(19):134-136,140.[doi:10.3969/j.issn.1006-1959.2023.19.029]
　HUO Chun-xia,XIE Ling,ZHANG Ai-ping.Effect of Early Intervention on Pregnancy Outcome of Pregnant Women with Early Screening Positive Preeclampsia[J].Journal of Medical Information,2023,36(19):134-136,140.[doi:10.3969/j.issn.1006-1959.2023.19.029]
点击复制

早期干预治疗对早期筛查阳性子痫前期孕妇妊娠结局的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年19期
页码:
134-136,140
栏目:
论著
出版日期:
2023-10-01

文章信息/Info

Title:
Effect of Early Intervention on Pregnancy Outcome of Pregnant Women with Early Screening Positive Preeclampsia
文章编号:
1006-1959（2023）19-0134-04
作者:
霍春霞; 谢 玲; 张爱萍
（青海红十字医院产一科，青海 西宁 810000）
Author(s):
HUO Chun-xia; XIE Ling; ZHANG Ai-ping
(The First Department of Obstetrics,Qinghai Red Cross Hospital,Xining 810000,Qinghai,China)
关键词:
子痫前期; 早期干预治疗; 妊娠结局
Keywords:
Preeclampsia; Early intervention treatment; Pregnancy outcome
分类号:
R714.24+4
DOI:
10.3969/j.issn.1006-1959.2023.19.029
文献标志码:
A
摘要:
目的 分析早期干预治疗对早期筛查阳性子痫前期孕妇妊娠结局的影响。方法 选取2021年1月-2022年12月我院收治的45例早期筛查阳性子痫前期孕妇为研究对象，采用随机数字表法分为观察组（n=23）和对照组（n=22）。对照组给予常规治疗，观察组在对照组基础上给予阿司匹林肠溶片进行早期干预治疗，比较两组临床治疗效果、血清可溶性fms样酪氨酸激酶-1（sFlt-1）、胎盘生长因子（PLGF）水平、孕妇不良妊娠结局发生率、并发症发生率、不良反应发生率。结果 观察组治疗总有效率为95.65%，高于对照组的81.82%（P＜0.05）；观察组治疗后PLGF水平高于对照组，sFlt-1水平低于对照组（P＜0.05）；观察组孕妇并发症发生率为13.04%，低于对照组的45.45%（P＜0.05）；观察组胎儿不良妊娠结局发生率为8.70%，低于对照组的36.36%（P＜0.05）；观察组不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）。结论 早期干预治疗可提升早期筛查阳性子痫前期孕妇的治疗疗效，降低孕妇并发症发生率，改善胎儿不良妊娠结局，提高PLGF水平，降低sFlt-1水平，且不会增加不良反应。
Abstract:
Objective To analyze the effect of early intervention on pregnancy outcome of pregnant women with early screening positive preeclampsia.Methods A total of 45 pregnant women with early screening positive preeclampsia admitted to our hospital from January 2021 to December 2022 were selected as the research objects. They were divided into observation group (n=23) and control group (n=22) by random number table method. The control group was given routine treatment, and the observation group was given aspirin enteric-coated tablets for early intervention on the basis of the control group. The clinical efficacy, serum soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PLGF) levels, incidence of adverse pregnancy outcomes, incidence of complications, and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.65%, which was higher than 81.82% in the control group(P<0.05). The PLGF level in the observation group was higher than that in the control group, and the sFlt-1 level was lower than that in the control group(P<0.05). After treatment, the incidence of complications in the observation group was 13.04%, which was lower than 45.45% in the control group (P<0.05). The incidence of fetal adverse pregnancy outcomes in the observation group was 8.70%, which was lower than 36.36% in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusion Early intervention treatment can improve the therapeutic effect for pregnant women with early screening positive preeclampsia, reduce the incidence of complications, improve fetal adverse pregnancy outcomes, increase PLGF level, reduce sFlt-1 level, and will not increase adverse reactions.

参考文献/References:

[1]孙秀荣,邓宇傲,陈学琳,等.子宫动脉超声定量分析联合血管内皮功能相关因子变化与子痫前期发病的相关性分析[J].湖南师范大学学报(医学版),2019,16(2):19-22.[2]刘婷婷,王娟妮,吴晓玲,等.序贯性子宫动脉超声、光电容积脉搏波联合血清学指标检测对妊娠高血压、子痫前期的诊断价值研究[J].新疆医科大学学报,2019,42(11):1423-1429.[3]中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4):227-238.[4]刘纪君,李雪蕾,陈红波,等.孕早期PlGF联合PAPP-A、MAP、UtPI预测子痫前期的临床应用研究[J].临床输血与检验,2022,24(4):476-481.[5]王玉.凝血四项、血清TNF-α及D-D在子痫前期患者中的临床诊断意义[J].湖南师范大学学报(医学版),2019,16(6):126-128.[6]郑海娜,赵维英.检测sFlt-1、PIGF、25-羟基维生素D、D-二聚体诊断子痫前期价值[J].中国计划生育学杂志,2018,26(12):1235-1238.[7]Bian X,Biswas A,Huang X,et al.Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia[J].Hypertension,2019,74(1):164-172.[8]王宇华,杨宾烈,张爱,等.早发型与晚发型重度子痫前期对围产结局影响[J].现代仪器与医疗,2016,22(2):42-43,49.[9]张燕,林曼,王秀妹.妊娠期糖尿病并发子痫前期患者血清Lipocalin-2、sFlt-1、PIGF水平及临床意义[J].临床和实验医学杂志,2017,16(18):1844-1847.[10]杨勉,回广飞.妊娠早期血清可溶性血管内皮生长因子受体-1、促血管生成因子与子痫前期相关性研究[J].临床军医杂志,2019,47(7):700-701.[11]贾冬丽,方丽丽,司晓辉.血清PDGF-BB、PIGF和sFlt-1水平检测在预测子痫前期发生中的意义[J].安徽医药,2018,22(4):685-688.[12]李笑天.子痫前期的定义、分类及其循证依据[J].中国实用妇科与产科杂志,2018,34(5):471-474.[13]赵影庭,卢海英,刘玮.血清PLGF、sFlt-1和sEng水平与妊娠期高血压和子痫前期的严重程度及其不良结局关系[J].中国妇幼保健,2019,34(12):2714-2716.[14]颜露春,朱广源,李小林,等.子痫前期孕妇外周血sFlt-1、PIGF、PP-13、sEng的表达及其与子宫动脉血流的相关性研究[J].中国生育健康杂志,2019,30(3):237-240,247.[15]徐丽娟,傅向红,纪毅梅,等.阿司匹林联合低分子肝素改善子痫前期母婴预后的临床应用价值[J].中国妇幼保健,2021,36(10):2212-2215. [16]卢涛,郝建民,张凯.胎盘生长因子与可溶性血管内皮生长因子受体-1预测子痫前期高危孕妇发病的价值研究[J].中国医学工程,2019,27(7):23-26.[17]王真,岳华.低分子肝素联合阿司匹林对子痫前期患者母婴结局的影响[J].实用临床医药杂志,2019,23(17):99-102. [18]马玲,马荣虎,樊杨.阿司匹林用于预防子痫前期及改善母儿结局的临床研究[J].甘肃科技,2022,38(12):88-91.

相似文献/References:

[1]李仲均,黄丽姗,曾带娣,等.孕妇血清维生素A、维生素E、25-羟基维生素D与 子痫前期的相关性研究[J].医学信息,2019,32(11):63.[doi:10.3969/j.issn.1006-1959.2019.11.018]
　LI Zhong-jun,HUANG Li-shan,ZENG Dai-di,et al.Correlation between Serum Vitamin A,Vitamin E,25-hydroxyvitamin D and Pre-eclampsia in Pregnant Women[J].Journal of Medical Information,2019,32(19):63.[doi:10.3969/j.issn.1006-1959.2019.11.018]
[2]尤 鑫,崔洪艳.PDGF与子痫前期相关性的研究进展[J].医学信息,2019,32(17):53.[doi:10.3969/j.issn.1006-1959.2019.17.017]
　YOU Xin,CUI Hong-yan.Advances in Research on the Relationship between PDGF and Preeclampsia[J].Journal of Medical Information,2019,32(19):53.[doi:10.3969/j.issn.1006-1959.2019.17.017]
[3]蒋峰丽,马亚楠,乌 丽.胎盘生长因子在子痫前期早期诊断中的临床价值[J].医学信息,2019,32(16):160.[doi:10.3969/j.issn.1006-1959.2019.16.054]
　JIANG Feng-li,MA Ya-nan,WU Li.Clinical Value of Placental Growth Factor in Early Diagnosis of Preeclampsia[J].Journal of Medical Information,2019,32(19):160.[doi:10.3969/j.issn.1006-1959.2019.16.054]
[4]王金凤,王克涛.红细胞压积、血清纤维蛋白原、D-二聚体及尿白蛋白/尿肌酐比值在子痫前期诊断中的价值[J].医学信息,2020,33(20):156.[doi:10.3969/j.issn.1006-1959.2020.20.049]
　WANG Jin-feng,WANG Ke-tao.The Value of Hematocrit,Serum Fibrinogen,D-dimer and Urine Albumin/Urinary Creatinine Ratio in the Diagnosis of Preeclampsia[J].Journal of Medical Information,2020,33(19):156.[doi:10.3969/j.issn.1006-1959.2020.20.049]
[5]史爱红,刘爱玲,封 玲,等.凝血功能指标对不同类型子痫前期的诊断价值[J].医学信息,2020,33(21):90.[doi:10.3969/j.issn.1006-1959.2020.21.026]
　SHI Ai-hong,LIU Ai-ling,FENG Ling,et al.The Diagnostic Value of Coagulation Function Indexes for Different Types of Preeclampsia[J].Journal of Medical Information,2020,33(19):90.[doi:10.3969/j.issn.1006-1959.2020.21.026]
[6]杨双燕,杨琦芳,李银凤.子痫前期病因及发病机制的研究[J].医学信息,2021,34(04):52.[doi:10.3969/j.issn.1006-1959.2021.04.014]
　YANG Shuang-yan,YANG Qi-fang,LI Yin-feng.Study on the Etiology and Pathogenesis of Preeclampsia[J].Journal of Medical Information,2021,34(19):52.[doi:10.3969/j.issn.1006-1959.2021.04.014]
[7]车 莹,杨 丽,孙 昊.前瞻性护理对妊娠高血压轻度子痫前期患者血压及自我管理能力的影响[J].医学信息,2022,35(02):190.[doi:10.3969/j.issn.1006-1959.2022.02.051]
　CHE Ying,YANG Li,SUN Hao.Effect of Prospective Nursing on Blood Pressure and Self-management Ability of Patientswith Mild Preeclampsia of Pregnancy-induced Hypertension[J].Journal of Medical Information,2022,35(19):190.[doi:10.3969/j.issn.1006-1959.2022.02.051]
[8]马梦茹,吴胜军,赵宗霞,等.子痫前期患者相关生化指标的研究进展[J].医学信息,2022,35(22):176.[doi:10.3969/j.issn.1006-1959.2022.22.043]
　MA Meng-ru,WU Sheng-jun,ZHAO Zong-xia,et al.Research Progress of Biochemical Indexes in Patients with Preeclampsia[J].Journal of Medical Information,2022,35(19):176.[doi:10.3969/j.issn.1006-1959.2022.22.043]
[9]郭 丽,黄淑娟,隋红梅.子痫前期的药物预防研究[J].医学信息,2023,36(23):170.[doi:10.3969/j.issn.1006-1959.2023.23.043]
　GUO Li,HUANG Shu-juan,SUI Hong-mei.Research on Drug Prevention of Preeclampsia[J].Journal of Medical Information,2023,36(19):170.[doi:10.3969/j.issn.1006-1959.2023.23.043]
[10]李 琳,李仲均.普伐他汀的作用机制及防治子痫前期的研究[J].医学信息,2024,37(05):178.[doi:10.3969/j.issn.1006-1959.2024.05.034]
　LI Lin,LI Zhong-jun.Study on the Mechanism of Pravastatin and its Prevention and Treatment of Preeclampsia[J].Journal of Medical Information,2024,37(19):178.[doi:10.3969/j.issn.1006-1959.2024.05.034]

更新日期/Last Update: 1900-01-01